Helicobacter pylori doesn’t fit neatly into either category. It’s not a harmless member of your normal gut bacteria, but it’s not a straightforward pathogen either. Roughly 44% of adults worldwide carry H. pylori in their stomachs, and the vast majority never develop any disease from it. That paradox has led researchers to classify it as something in between: an opportunistic organism that behaves like a commensal in most people but can turn pathogenic under certain conditions.
Why the Classification Is Complicated
Traditional pathogens cause disease in most of the people they infect. H. pylori doesn’t do that. Among those who carry it, only 10% to 15% develop peptic ulcers, fewer than 3% develop stomach cancer, and less than 1% develop a rare type of lymphoma called MALT lymphoma. The rest carry the bacterium for life with no symptoms at all.
That pattern looks far more like a commensal organism (one that lives on or in you without causing harm) than a true pathogen. A review in the World Journal of Gastroenterology concluded that the high prevalence of H. pylori across the global population and its asymptomatic coexistence with most carriers “clearly indicate that H. pylori is more likely to be an opportunistic or latent pathogen than a truly pathogenic bacterium.” The bacterium only becomes dangerous in certain hosts under certain conditions, which is the hallmark of an opportunist rather than an invader.
Still, because H. pylori is a recognized risk factor for stomach ulcers and gastric cancer, medical guidelines classify it as pathogenic. The World Health Organization has listed it as a Group 1 carcinogen since 1994. So the official classification leans toward pathogen, even though its day-to-day behavior in most carriers is closer to normal flora.
An Ancient Relationship With Humans
H. pylori has lived in human stomachs for at least 100,000 years. When early humans migrated out of Africa roughly 60,000 years ago, they carried their H. pylori strains with them. Genetic analysis of H. pylori populations around the world mirrors the map of human migration so precisely that researchers use the bacterium’s DNA to trace ancient population movements. When humans crossed the Bering Strait into the Americas, their H. pylori came along. After European colonization and the Atlantic slave trade, European and African strains largely replaced the original indigenous strains in the Americas.
This deep co-evolutionary history is one of the strongest arguments for viewing H. pylori as part of the human microbiome rather than a foreign invader. Organisms that have lived with a host species for tens of thousands of years typically develop a balanced relationship. The immune system initially mounts a response to H. pylori colonization, but over time this is replaced by immune tolerance, a pattern that looks more like symbiosis than infection.
How It Survives in the Stomach
Your stomach is one of the most hostile environments in your body, with acid strong enough to break down food and kill most bacteria. H. pylori survives by producing an enzyme called urease, which converts a compound naturally present in the stomach into ammonia. That ammonia neutralizes the acid in the bacterium’s immediate surroundings, creating a small pocket of near-neutral pH where it can thrive. When conditions become more acidic, a specialized channel in the bacterium’s membrane opens to bring in more raw material for this reaction, ramping up acid neutralization on demand.
Once it establishes itself beneath the stomach’s mucus layer, H. pylori can persist for decades. Without targeted treatment, most people carry it for life.
How You Pick It Up
H. pylori is almost always acquired during childhood, typically before age 10. It spreads primarily from person to person within families, particularly from mother to child through oral contact. A mother’s saliva can carry the bacterium, and young children in close contact with infected family members are the most common new cases.
Water and food contaminated under poor sanitary conditions can also transmit H. pylori, though the human stomach remains the only known natural reservoir. This is why prevalence is highest in regions with crowded living conditions and limited sanitation. The global prevalence has dropped from about 53% before 1990 to 44% in recent years among adults, largely due to improvements in hygiene and living standards. In children and adolescents, however, the rate hasn’t declined significantly and sits around 35%.
When It Causes Problems
In most carriers, H. pylori sits quietly in the stomach lining without triggering noticeable symptoms. But in a subset of people, it drives chronic inflammation that can progress to ulcers or, over decades, to gastric cancer. What determines whether someone stays asymptomatic or develops disease involves a combination of the specific bacterial strain, the host’s genetics, and environmental factors like diet and smoking.
Certain strains of H. pylori carry a gene called cagA, which makes them significantly more likely to cause disease. Interestingly, these same cagA-positive strains that increase the risk of cancer in the lower part of the stomach appear to protect against cancer in the upper stomach and lower esophagus. This dual nature further complicates the simple question of whether H. pylori is “good” or “bad.”
Potential Protective Effects
One of the more provocative findings in H. pylori research is its inverse relationship with allergies and asthma. Multiple studies across different populations have found that people carrying H. pylori are less likely to have these conditions. Some researchers argue that the disappearance of H. pylori from human stomachs in wealthier countries, where sanitation and antibiotic use have driven colonization rates down, may be contributing to the rise in allergic and autoimmune diseases.
This fits into the broader “disappearing microbiota” hypothesis: that organisms humans co-evolved with over millennia played regulatory roles in our immune systems, and removing them creates imbalances. The co-evolution of H. pylori and humans over 100,000 years may be coming to an end in affluent societies, and the consequences of that separation are still being understood.
What This Means if You Test Positive
If you’ve tested positive for H. pylori and have no symptoms, the question of whether to treat it is less straightforward than it might seem. Current guidelines from the American College of Gastroenterology recommend treatment for people with confirmed H. pylori infection, particularly those with ulcers, a history of stomach cancer in their family, or persistent digestive symptoms. The rationale is that even asymptomatic carriers have an elevated long-term risk of gastric cancer, and eradication eliminates that risk.
But the fact that fewer than 3% of carriers ever develop cancer, combined with the potential protective effects and the heavy antibiotic regimens required for treatment, means the decision involves weighing small but real risks on both sides. Your individual risk depends on factors like your family history, where you grew up, and what strain you carry.
The bottom line: H. pylori is not normal flora in the way that, say, the billions of bacteria in your colon are. It’s a distinct organism acquired from other people, not inherited as part of your body’s natural ecosystem. But it’s also not a straightforward pathogen. For most of the people on Earth who carry it, it behaves more like a permanent, quiet tenant than a disease-causing invader.